Hippocampal protein extracts from 5xFAD mice following long-term (three-month) oral Avn-C administration, initiated at the early AD stage, showed a marked ~27.3% increase in GSK3β Ser9 phosphorylation compared to 5xFAD vehicles (p < 0.001). This evidence concerns the gene GSK3B and Alzheimer disease.